Home › NDC Lookup › RxCUI directory › RxCUI 1099279

Docusate sodium 100 MG Oral Tablet — RxCUI 1099279

Name: Docusate sodium 100 MG Oral Tablet (RxCUI 1099279)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1099279 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1099279

Official nameDocusate sodium 100 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asDOSS Sodium 100 MG Oral Tablet

FDA products mapped3

Package NDCs mapped5

Reported Medicaid activity (SDUD)71,024 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Docusate sodium 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Docusate sodium 100 MG Oral Tablet RxCUI 1099279 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Docusate 82003 IN
- Docusate sodium 71722 PIN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- DOK 216344 BN
- Promolaxin 1099274 BN
Dose forms 17

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Docusate Oral Tablet 371949 SCDF
- Docusate sodium Oral Tablet 2648675 SCDFP
- Docusate Oral Product 1160200 SCDG
- Docusate Pill 1160202 SCDG
- Docusate sodium Oral Product 2661151 SCDGP
- Docusate sodium Pill 2663394 SCDGP
- Docusate Oral Tablet [DOK] 1483573 SBDF
- Docusate Oral Tablet [Promolaxin] 1099276 SBDF
- +9 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Docusate sodium 100 MG 1099278 SCDC
- Docusate sodium 100 MG Oral Tablet [DOK] 1483574 SBD
- Docusate sodium 100 MG Oral Tablet [Promolaxin] 1099281 SBD
- Docusate sodium 100 MG [DOK] 1483567 SBDC
- Docusate sodium 100 MG [Promolaxin] 1099280 SBDC

Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Docusate sodium 100 MG SCDC · 1099278
Docusate Oral Tablet SCDF · 371949
Docusate sodium Oral Tablet SCDFP · 2648675
Docusate Oral Product SCDG · 1160200
Docusate Pill SCDG · 1160202
Docusate sodium Oral Product SCDGP · 2661151
Docusate sodium Pill SCDGP · 2663394

Brand-Name Concepts

Docusate sodium 100 MG Oral Tablet [DOK] SBD · 1483574
Docusate sodium 100 MG Oral Tablet [Promolaxin] SBD · 1099281
Docusate sodium 100 MG [DOK] SBDC · 1483567
Docusate sodium 100 MG [Promolaxin] SBDC · 1099280
Docusate Oral Tablet [DOK] SBDF · 1483573
Docusate Oral Tablet [Promolaxin] SBDF · 1099276
Docusate sodium Oral Tablet [DOK] SBDFP · 2657772
Docusate sodium Oral Tablet [Promolaxin] SBDFP · 2656525
DOK Oral Product SBDG · 1483569
DOK Pill SBDG · 1483570

📦 FDA Products & Package NDCs

3 products · 5 package NDCs

5 package NDCs map to RxCUI 1099279 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00904-6750-60	100 TABLET in 1 BOTTLE (0904-6750-60)	DOK	MAJOR PHARMACEUTICALS	2018-06-01
57896-0421-01	100 TABLET in 1 BOTTLE (57896-421-01)	STOOL SOFTENER	Geri-Care Pharmaceuticals, Corp	2015-09-01
57896-0421-10	1000 TABLET in 1 BOTTLE (57896-421-10)	STOOL SOFTENER	Geri-Care Pharmaceuticals, Corp	2015-09-01
57896-0421-20	200 TABLET in 1 BOTTLE (57896-421-20)	STOOL SOFTENER	Geri-Care Pharmaceuticals, Corp	2019-05-01
70677-1071-01	1 BOTTLE in 1 CARTON (70677-1071-1) / 100 TABLET in 1 BOTTL...	Stool Softener	STRATEGIC SOURCING SERVICES LLC	2023-06-01

Observed labelers: Geri-Care Pharmaceuticals, Corp (3) · MAJOR PHARMACEUTICALS (1) · STRATEGIC SOURCING SERVICES LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.0385

Range $0.0385–$0.0385 · middle 50% $0.0385–$0.0385 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.